2. Cholesterol Metabolism
Sources of cholesterol
Cholesterol synthesis
Long and short term regulation
SREBP-2
Lowering cholesterol
Calculating your risk for CHD
4. Sources of Cholesterol
Diet De novo synthesis
Cholesterol synthesized
in extrahepatic tissues
Liver cholesterol
pool
Free cholesterol
In bile
Conversion to bile salts/acidsSecretion of HDL
and VLDL
7. Dietary Cholesterol
Assume 400 mg intake / day
200 mg is absorbed
1000 mg is excreted
800 mg from de novo synthesis
Lowering cholesterol in diet has very little effect on
blood cholesterol !!!
8. Cholesterol Synthesis
Similar to ketogenic pathway
Occurs in cytosol
Requires NADPH and ATP
Highly regulated
80 % in liver, ~10% intestine, ~5% skin
10. HMG CoA Reductase : Regulation
Short-term regulation
Inhibited by phosphorylation
AMP-dependent protein kinase
When AMP is high (or ATP low!), why waste energy on
cholesterol synthesis
Long-term regulation
Proteolysis
Degradation stimulated by cholesterol and cholesterol
metabolites
Sterol-sensing domain
11. HMG CoA reductase -
Phosphorylation
AMP-Activated
Protein Kinase (high activity)
AMP-Activated
Protein Kinase
(low activity)
phosphatase
insulin
(+)
kinase
Glucagon/epi
(+)
increase cAMP
AMP
(+)
HMG CoA reductase – OH
(active)
HMG CoA reductase – P
(inactive)
12. HMG CoA Reductase : Regulation
Transcriptional regulation
SREBP-2
Responds to cellular levels of sterols
18. Lowering Cholesterol
Bile sequestering agents
Bile
acids
liver
Bile acids
95 % reabsorbed
5% in feces
NH3+
NH3+
1. Bind bile acid
2. Utilize more cholesterol
to make bile acids
>10% in feces
19. Lowering Cholesterol
Oat bran
Soluble fiber
Bind bile acids?
Niacin
3-8 grams / day (need 60 mg)
Inhibits VLDL excretion ? (fatty liver)
Flushing and liver damage